Sleeping Pills, Anti-Anxiety Drugs May Double Risk of Death: Study

Prolonged use of drugs such as Ambien and Xanax may increase a person’s risk of early death, according to the findings of new research.   

In a study published this month in BMJ (British Medical Journal), researchers from the University of Warwick in the United Kingdom indicate that patients who took anti-anxiety medication or sleep aids were found to have more than double the risk of death when compared those who didn’t take the drugs.

Researchers compiled information from more than 270,000 primary care practices in the U.K. from 1998 to 2001, adding the data to the General Practice Research Database. Nearly 35,000 patients over the age of 16 received prescriptions for anxiolytic drugs, like Valium and Xanax, or hypnotic drugs, including Ambien, Sonata and Lunesta. Some patients took both types of drugs.

Did You Know?

Change Healthcare Data Breach Impacts Millions of Customers

A massive Change Healthcare data breach exposed the names, social security numbers, medical and personal information of potentially 100 million Americans, which have now been released on the dark web. Lawsuits are being pursued to obtain financial compensation.

Learn More

Patients who took the sedative or hypnotic drugs were compared to a control group of nearly 70,000 patients who did not take prescriptions for either anti-anxiety or sleep drugs. Participants were followed for seven years, with researchers accounting for sleep disorders, anxiety disorders and other psychiatric illnesses.

The study found that those who took drugs like Xanax or Ambien had a more than double the risk of earlier death. For every 100 people who took the drugs, four additional deaths were linked to taking sedative-hypnotic medications, according to the researchers.

The findings add to a growing body of evidence that suggests side effects of sleeping pills and anxiety drugs may be significantly more harmful than doctors previously believed.

Last year, a group of doctors backed the FDA’s decision to require new label warnings and lower dosages for Ambien and other sleep drugs. The move for updated label changes for sleeping drugs followed evidence revealing the effect the drugs have in impairing consumers taking the drugs before driving.

Additional research revealed drugs like Valium and Lunesta cause lingering effects in patients. The medications often impair users well into the following day, including side effects like prolonged drowsiness and impaired alertness.

Doctors warn that taking sleep aids over the long term can result in addiction and dependency, recommending that users spend as little time taking the drugs as possible.

0 Comments

Share Your Comments

I authorize the above comments be posted on this page*

Want your comments reviewed by a lawyer?

To have an attorney review your comments and contact you about a potential case, provide your contact information below. This will not be published.

NOTE: Providing information for review by an attorney does not form an attorney-client relationship.

This field is for validation purposes and should be left unchanged.

More Top Stories

Hair Relaxer Lawsuit Status Conference To Be Held With MDL Judge This Week
Hair Relaxer Lawsuit Status Conference To Be Held With MDL Judge This Week (Posted 2 days ago)

U.S. District Judge presiding over all federal hair relaxer lawsuits will meet with lawyers involved in the litigation on Thursday, to discuss the status of the claims and when to move forward with bellwether cases.

Lawyers Propose MDL Trial Dates for Baby Formula NEC Lawsuit Starting in May 2025
Lawyers Propose MDL Trial Dates for Baby Formula NEC Lawsuit Starting in May 2025 (Posted 3 days ago)

A series of four bellwether claims in the baby formula NEC lawsuit MDL will be ready to go before a federal juries in May 2025, August 2025, November 2025 and February 2026 according to a proposed trial schedule agreed upon by both plaintiffs and defendants.